Open-label Pilot Study of Interferon Gamma-1b (Actimmune™) for the Treatment of Friedreich Ataxia (FRDA)
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Friedreich's ataxia
- Focus Pharmacodynamics
- 13 Oct 2014 Results published in a Horizon Pharma media release.
- 13 Oct 2014 Results were presented at the the Children's Hospital of Philadelphia (CHOP) 7th Annual Friedreich's Ataxia (FA) Symposium and are being discussed at the Horizon analyst day, according to a Horizon Pharma media release.
- 09 Oct 2014 According to a Horizon Pharma media release, data was published in an abstract in Annals of Neurology and presented at the 139th Annual Meeting of the American Neurological Association.